| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/16/2013 | CN102872208A Method for manufacturing Shuanghuanglian oral liquid |
| 01/16/2013 | CN102872201A Method for extracting general flavones from folium mori |
| 01/16/2013 | CN102872173A Compound acetaminophen orally disintegrating tablet for beasts and birds and preparation method for compound acetaminophen orally disintegrating tablet |
| 01/16/2013 | CN102872066A Ivermectin and application of derivative thereof |
| 01/16/2013 | CN102872037A Application of Gypensapogenin B in medicaments against aseptic inflammation |
| 01/16/2013 | CN102872022A Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102871994A Flurbiprofen acetaminophen ester cyclodextrin inclusion compound and preparation method thereof |
| 01/16/2013 | CN102871981A Tablet medicine compound containing levetiracetam |
| 01/16/2013 | CN102871957A Dexibuprofen intravenous administration preparation and preparation method thereof |
| 01/16/2013 | CN102871952A Flurbiprofen acetaminophen ester solid dispersion and preparation method thereof |
| 01/16/2013 | CN102871950A 一种熊果酸固体分散体及其制备方法 One kind of ursolic acid solid dispersion and its preparation method |
| 01/16/2013 | CN102871910A Body wash for clearing summer heat |
| 01/16/2013 | CN102871905A Antifebrile facial cleanser |
| 01/16/2013 | CN102871897A Peppermint tooth care mouth wash |
| 01/16/2013 | CN102871881A Antiphlogistic toothpaste |
| 01/16/2013 | CN102871790A Herbal thermal patch and production method thereof |
| 01/16/2013 | CN102240391B Traditional Chinese medicine solution for health promotion |
| 01/16/2013 | CN102228556B Externally applied drug for fumigating treatment of arthritis |
| 01/16/2013 | CN101948543B Fusion protein and coding gene and application thereof |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
| 01/16/2013 | CN101480376B Method of preparing particles for agglomeration |
| 01/16/2013 | CN101474217B Antiphlogistic analgesic Capparis spinosa L. catablasm and preparation method thereof |
| 01/16/2013 | CN101306191B Use of TLR2 ligand PGN in treating metabolism syndrome |
| 01/15/2013 | US8354416 3-[2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-5-fluoro-4-methyl-N-(1-methylethyl)benzamide; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs; mitogen-activated protein kinase inhibitors |
| 01/15/2013 | US8354415 Thienopyrimidine compounds and compositions |
| 01/15/2013 | CA2677095C Improved reduced irritant enema for the treatment of inflammatory bowel disease (ibd) |
| 01/15/2013 | CA2571742C Canine osteoarthritis diet formulation |
| 01/15/2013 | CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 01/15/2013 | CA2424607C Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 01/10/2013 | WO2013006758A1 Diphosphate mimetics and uses thereof |
| 01/10/2013 | WO2013006333A1 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc) |
| 01/10/2013 | WO2013005755A1 Methylpiperidine derivative |
| 01/10/2013 | WO2013005698A1 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 01/10/2013 | WO2013005226A1 A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same |
| 01/10/2013 | WO2013004996A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain |
| 01/10/2013 | WO2013004462A1 A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
| 01/10/2013 | WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists |
| 01/10/2013 | WO2013004123A1 Ibuprofen chewable tablet |
| 01/10/2013 | WO2012158964A3 Improved peptide pharmaceuticals for osteoporosis |
| 01/10/2013 | WO2012106722A3 Treatment of bacterial infections |
| 01/10/2013 | WO2012075287A3 Novel selective inhibitors of prolylcarboxypeptidase |
| 01/10/2013 | US20130012588 Compositions and methods for prevention and treatement of wounds |
| 01/10/2013 | US20130012585 Phenylacetic Acid Derivatives |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012575 Plant extract from low-thc cannabis for the treatment of disease |
| 01/10/2013 | US20130012573 Methods for intracellular delivery of nucleic acids |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012565 4-hydroxybutyric acid analogs |
| 01/10/2013 | US20130012548 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012537 3,8-diaminotetrahydroquinoline derivative |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012530 New Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/10/2013 | US20130012526 Oxazole derivatives useful as modulators of faah |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012504 Bi-functional quinoline analogs |
| 01/10/2013 | US20130012500 Organic compounds |
| 01/10/2013 | US20130012499 Trpv4 antagonists |
| 01/10/2013 | US20130012494 Cyclopropyl-fused-1,3-thiazepines as bace1 and/or bace2 inhibitors |
| 01/10/2013 | US20130012492 Fused heterocyclic compounds as ion channel modulators |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012486 Combination steroid and glucocorticoid receptor antagonist therapy |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012484 Petroleum jelly-free unguent compositions comprising vitamin d compounds and optionally steroidal anti-inflammatory agents |
| 01/10/2013 | US20130012482 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012472 Composition and methods of inhibiting gastrointestinal pathogen infection |
| 01/10/2013 | US20130012464 Glycyrrhizinates of morphinan derivatives |
| 01/10/2013 | US20130012463 Identification of free-b-ring flavonoids as potent cox-2 inhibitors |
| 01/10/2013 | US20130012445 Compositions for Improving Bone Mass |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012438 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| 01/10/2013 | US20130012432 Peptides for Treatment of Obesity |
| 01/10/2013 | US20130012427 Polypeptides |
| 01/10/2013 | US20130011852 Compounds that interact with kinases |
| 01/10/2013 | US20130011501 Anti-Fever Botanical Composition and Uses Thereof |
| 01/10/2013 | US20130011482 Dual component medicament delivery system |
| 01/10/2013 | US20130011475 Stable compositions of famotidine and ibuprofen |
| 01/10/2013 | US20130011470 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 01/10/2013 | US20130011453 Buffered microencapsulated compositions and methods |
| 01/10/2013 | US20130011445 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 01/10/2013 | US20130011415 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof |
| 01/10/2013 | US20130011406 Anti-kit antibodies and uses thereof |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011399 WAP Domain Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011397 Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011390 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/10/2013 | US20130011368 Metabolically Active Micro-Organisms and Methods for Their Production |
| 01/10/2013 | US20130011342 Surfactant-free, water-free formable composition and breakable foams and their uses |
| 01/10/2013 | CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists |
| 01/10/2013 | CA2835232A1 A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |